Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

FDA completes inspection of Catalent Pharma's manufacturing facility in Germany

Catalent Pharma Solutions announces that its integrated dose form development, manufacturing and packaging facility in Schorndorf, Germany, has successfully completed an FDA inspection.

7 Oct 2009

Imagexpres inks distributor/supply agreement with Dalton Corporation

ImageXpres Corporation, today announced it has signed a Distributor/Supply Agreement with Dalton Corporation, a Taiwan-based manufacturer of digital hardware and software products, that are sold throughout the world, including private label for well-known brands.

7 Oct 2009

Fully validated assay to detect the presence of Calicivirus 2117 in biological samples

BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.

7 Oct 2009

Uroplasty's Urgent PC and Macroplastique presented at the International Continence Society Meeting

Uroplasty, Inc., a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today highlighted presentations, workshops and posters focused on its products at the 39th Annual Meeting of the International Continence Society Meeting (ICS), September 29 - October 3 in San Francisco.

7 Oct 2009

African leaders gather to discuss ways to bolster continent's drug, diagnostic development

Business Day examines efforts currently underway in Africa to bolster the continent's ability to develop new drugs and diagnostics.

7 Oct 2009

Catalent Pharma Solutions' Corby packaging facility receives High Commendation recognition

Catalent Pharma Solutions announces that its commercial packaging facility in Corby, United Kingdom, received a High Commendation recognition in the Judge’s Special Award category, in the recently announced “2009 Best Factory Awards.” The Corby facility was nominated in several categories, including “Best Process Factory” and “Overall Best UK Factory.”

6 Oct 2009

Ground Zero Pharmaceuticals opens new office in Brisbane

A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.

6 Oct 2009

mtm laboratories signs additional tranche of Euro 7 million to its Series C funding

mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company’s last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.

6 Oct 2009

Scientia Advisors announces the results of an in-depth study of the changing vaccine industry

Technological breakthroughs, national immunization programs and emerging vaccines for treating, rather than preventing, disease are priming the global vaccine market for growth.

6 Oct 2009

MD Biosciences' new location increases capacity for in vitro services and product development

MD Biosciences (MDB), a contract research organization offering pre-clinical services and products in support of drug discovery for inflammatory and neurological diseases, relocated its U.S. office from 1000 Westgate Dr, St Paul, MN to 2575 University Ave W, St Paul, MN on October 3, 2009.

6 Oct 2009

St. Jude Children’s Research Hospital researcher receives the Millipore Guava Flow Cytometry Award

Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today awarded Dr. Mari Hashitate Dallas of St. Jude Children’s Research Hospital in Memphis, Tenn., the Millipore Guava® Flow Cytometry Award.

6 Oct 2009

Cardiovascular Systems to build new manufacturing facility in Texas

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed a 10-year lease agreement for a new 46,000-square-foot manufacturing facility in Pearland, Texas.

6 Oct 2009

Vivaldi receives US patent for live attenuated influenza vaccines

Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.

6 Oct 2009

Inviragen, SingVax merge their complementary vaccine pipelines

Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for infectious diseases prevalent in emerging economies.

6 Oct 2009

ResMed announces acquisition of Laboratoires Narval

ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced today that it has acquired Laboratoires Narval. Based in France, Laboratoires Narval manufactures and distributes the Narval O.R.M.(TM), an innovative mandibular repositioning device (MRD) that offers a solution to patients for snoring and obstructive sleep apnea (OSA), especially for those with mild OSA.

From ResMed Corp 6 Oct 2009

Guided Therapeutics awarded $2.5M NCI grant for marketing LightTouch technology

Guided Therapeutics, Inc. today announced that it was awarded a $2.5 million matching grant by the National Cancer Institute (NCI) to bring to market and expand the array features for its LightTouch™ non-invasive cervical cancer detection technology. The award provides resources to complete the regulatory process and begin manufacturing ramp up for the device and single-patient-use disposable.

6 Oct 2009

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

Las Vegas-based Endogenous Stem Cells Activators Inc. (ESAI) announced today that it will award a $1.3 million grant to Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LABioMed) for pre-clinical studies aimed at activating penile endogenous (adult) stem cells with the company's drug, KRONOS IV.

5 Oct 2009

Bausch & Lomb announces acquisition of Tubilux Pharma's commercial assets

Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A.

5 Oct 2009

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus (SynConTM) H1N1 influenza vaccine candidates achieved protective antibody responses against the novel pandemic influenza A/H1N1 (2009) in 100% of tested ferrets.

5 Oct 2009

PAC introduces ANTEK MultiTek testing system

PAC, a leading global provider of advanced analytical instruments for laboratories and online process applications, announces the introduction of the ANTEK MultiTek(TM) testing system for the fast, accurate detection of sulfur, nitrogen, and halides. Industries include BioFuels, Chemicals, Food & Beverage, Manufacturing and Assembly, Medical, Pharmaceutical, Environmental, and many more.

5 Oct 2009

Manufacturing News and Research

Further Reading

FDA completes inspection of Catalent Pharma's manufacturing facility in Germany

Imagexpres inks distributor/supply agreement with Dalton Corporation

Fully validated assay to detect the presence of Calicivirus 2117 in biological samples

Uroplasty's Urgent PC and Macroplastique presented at the International Continence Society Meeting

African leaders gather to discuss ways to bolster continent's drug, diagnostic development

Catalent Pharma Solutions' Corby packaging facility receives High Commendation recognition

Ground Zero Pharmaceuticals opens new office in Brisbane

mtm laboratories signs additional tranche of Euro 7 million to its Series C funding

Scientia Advisors announces the results of an in-depth study of the changing vaccine industry

MD Biosciences' new location increases capacity for in vitro services and product development

St. Jude Children’s Research Hospital researcher receives the Millipore Guava Flow Cytometry Award

Cardiovascular Systems to build new manufacturing facility in Texas

Vivaldi receives US patent for live attenuated influenza vaccines

Inviragen, SingVax merge their complementary vaccine pipelines

ResMed announces acquisition of Laboratoires Narval

Guided Therapeutics awarded $2.5M NCI grant for marketing LightTouch technology

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

Bausch & Lomb announces acquisition of Tubilux Pharma's commercial assets

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

PAC introduces ANTEK MultiTek testing system

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News